OBI Pharma Inc
TPEX:4174
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
OBI Pharma Inc
TPEX:4174
|
TW |
|
M
|
MSC Co Ltd
KOSDAQ:009780
|
KR |
|
E
|
Exco Technologies Ltd
OTC:EXCOF
|
CA |
|
M
|
More Impact AG
DUS:AEE1
|
DE |
|
Greenbriar Sustainable Living Inc
XTSX:GRB
|
CA |
|
Microport Scientific Corp
F:MSK
|
KY |
|
T
|
Texas Roadhouse Inc
SWB:ROW
|
US |
|
Cann Group Ltd
ASX:CAN
|
AU |
|
Surgutneftegaz PAO
MOEX:SNGS
|
RU |
|
FS KKR Capital Corp
NYSE:FSK
|
US |
|
Creative Vistas Inc
OTC:CVAS
|
CA |
|
H
|
Hammer Metals Ltd
F:6HM
|
AU |
|
W
|
Webuild SpA
F:IPJ1
|
IT |
|
D
|
Domo Inc
SWB:1ON
|
US |
|
Gke Corporation Ltd
SGX:595
|
SG |
Bankruptcy Probability
OBI Pharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
OBI Pharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
O
|
OBI Pharma Inc
TPEX:4174
|
7.1B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
OBI Pharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, OBI Pharma Inc has total debt of 330.6m TWD. This includes both short-term (68.4m TWD) and long-term (262.2m TWD) debt.
You can find a full breakdown on its Balance Sheet.